πŸ‡ΊπŸ‡Έ FDA
Patent

US 9644018

Antibody modulators of APLNR

granted A61KA61K38/00A61K38/08

Quick answer

US patent 9644018 (Antibody modulators of APLNR) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/22